Skip to content

Role of the Second Medicine in Treating Long-Term (Chronic) Disease

Utility and relevance of second prescription in cases of chronic diseases- A clinical observational study - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110211
Enrollment
48
Registered
2026-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified Health Condition 2: I10- Essential (primary) hypertension Health Condition 3: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Individualized Homoeopathy medicine: Individualized homoeopathy medicine on the basis of totality of symptoms and repertorisation Control Intervention1: NIL: Nil

Sponsors

Dr Shivam Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient suffering from chronic disease without systemic complications. 2. Patient of both sexes between the age group 18 to 65 years. 3. Patient willing to regular follow up. 4. Case treated with classical Homoeopathy

Exclusion criteria

Exclusion criteria: 1. Patient with acute diseases or emergencies. 2. Pregnant or lactating women. 3. Patient lost to regular follow up or with incomplete clinical records. 4. Mentally incapasitated patient

Design outcomes

Primary

MeasureTime frame
Access the most common type and frequency of second prescription as well the reduction in suffering as measured by MONARCH criteria from baseline to 12 week of treatment.Timepoint: 12 week

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sanjay Kumar Singh

R.B.T.S. Government Homoeopathic medical College and hospital

sanjaydr1981@gmail.com9304078805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026